Fifteen patients in Sangrur experienced mild reactions after receiving intravenous glucose at the civil hospital. Authorities withdrew the affected batch. AAP MLA Narinder Kaur Bharaj and Punjab ...

Positive preliminary data from all five single ascending dose (SAD) cohorts and first three completed multiple ascending dose (MAD) cohorts support safety and tolerability of PALI-2108 No serious ...

Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA), a clinical stage biopharmaceutical company that has been developing a treatment ...

Practitioners who can create holistic experiences, emphasizing self-care and fostering a sense of delight, will see patients ...